First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia

Medical Mycology

Volumn 50, Issue 7, 2012, Pages 746-750

  Caira, Morena ^a   Posteraro, Brunella ^a   Sanguinetti, Maurizio ^a   De Carolis, Elena ^a   Leone, Giuseppe ^a   Pagano, Livio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Acute myeloid leukemia; Antifungal susceptibility; Aspergillosis; Aspergillus nomius; Breakthrough

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CEFTAZIDIME; CYTARABINE; ETOPOSIDE; GALACTOMANNAN; MITOXANTRONE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; ASPERGILLUS NOMIUS; ASPERGILLUS NOMIUS INFECTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FUNGUS IDENTIFICATION; HUMAN; IN VITRO STUDY; LOADING DRUG DOSE; LUNG ASPERGILLOSIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL COUNT; NONHUMAN;

AGED; ANTIFUNGAL AGENTS; ASPERGILLUS; ECHINOCANDINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MYCOLOGY; PHYLOGENY; PULMONARY ASPERGILLOSIS; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ASPERGILLUS NOMIUS;

EID: 84866493787     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.660507     Document Type: Article

References (28)

1. Krishnan S, Manavathu EK, Chandrasekar PH. A spergillus fl avus: An emerging non-fumigatus Aspergillus species of signifi cance. Mycoses 2009; 52: 206-222.
2. Pagano L, Caira M, Candoni A, et al . Invasive aspergillosis in patients with acute myeloid leukemia: A SEIFEM-2008 registry study. Haematologica 2010; 95: 644-650.
3. Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW. Aspergillus fl avus: Human pathogen, allergen and mycotoxin producer. Microbiology 2007; 153: 1677-1692.
4. Pasqualotto AC. Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus fl avus . Med Mycol 2009; 47: S261-270.
5. Varga J, Frisvad JC, Samson RA. Two new afl atoxin producing species, and an overview of Aspergillus section. Flavi . Stud Mycol 2011; 69: 57-80.
6. Balajee SA, Lindsley MD, Iqbal N, et al . Nonsporulating clinical isolate identifi ed as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods. J Clin Microbiol 2007; 45: 2701-2703.
7. Ozhak-Baysan B, Alastruey-Izquierdo A, Saba R, et al . Aspergillus alliaceus and Aspergillus fl avus co-infection in an acute myeloid leukemia patient. Med Mycol 2010; 48: 995-999.
8. Paludetti G, Rosignoli M, Ferri E, et al . Invasive nasosinusal aspergillosis in an immunocompetent patient. Acta Otorhinolaryngol Ita 1992; 12: 581-591 [In Italian].
9. Schwetz I, Horina J, Buzina W, et al . Aspergillus oryzae peritonitis in CAPD: Case report and review of the literature. Am J Kidney Dis 2007; 49: 701-704.
10. Manikandan P, Varga J, Kocsub éS, et al . Mycotic keratitis due to Aspergillus nomius . J Clin Microbiol 2009; 47: 3382-3385.
11. De Hoog GS, Guarro J, Gen éJ, Figueras MJ (eds.), A tlas of Clinica Fungi . Centraalbureau voor Schimmelcultures, Utrecht, NL, 2000.
12. de Carolis E, Posteraro B, Lass-Fl örl C, et al . Species identifi cation of Aspergillus, Fusarium and Mucorales using direct surface analysis by MALDI-TOF mass spectrometry. Clin Microbiol Infect 2011; Epub ahead of print.
13. Balajee SA, Houbraken J, Verweij PE, et al . A spergillus species identifi cation in the clinical setting. Stud Mycol 2007; 59: 39-46.
14. Balajee SA, Borman AM, Brandt ME, et al . Sequence-based identifi - cation of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: Where are we and where should we go from here? J Clin Microbiol 2009; 47: 877-884.
15. Posteraro B, Mattei R, Trivella F, et al . Uncommon Neosartorya udagawae fungus as a causative agent of severe corneal infection. J Clin Microbiol 2011; 49: 2357-2360.
16. Clinical and Laboratory Standards Institute. R eference Method fo Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, approved standard, document M38-A2, 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
17. Klich MA. Identifi cation of clinically relevant aspergilli. M ed Myco 2006; 44: 127-131.
18. Martino R, Viscoli C. Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin. Br J Haematol 2006; 132: 138-154.
19. Sun HY, Singh N. Characterisation of breakthrough invasive mycoses in echinocandin recipients: An evidence-based review. Int J Antimicrob Agents 2010; 35: 211-218.
20. Lafaurie M, Lapalu J, Raffoux E, et al . High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia. Clin Microbiol Infect 2010; 16: 1191-1196.
21. Bal AM. The echinocandins: Three useful choices or three too many? Int J Antimicrob Agents 2010; 35: 13-18.
22. Mayr A, Aigner M, Lass-Flörl C. Caspofungin: When and how? The microbiologist ' s view. C. Mycoses 2011; 55(1): 27-35.
23. Madureira A, Bergeron A, Lacroix C, et al . Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin. Int J Antimicrob Agents 2007 30: 551-554.
24. Viscoli C, Herbrecht R, Akan H, e t al. An EORTC Phase II study of caspofungin as fi rst-line therapy of invasive aspergillosis in haematological patients. J Antimicrob Chemother 2009; 64 :1274-1281.
25. Herbrecht R, Maertens J, Baila L, et al . Caspofungin fi rst-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: A European Organisation for Research and Treatment of Cancer study. Bone Marrow Transplant 2010; 45 :1227-1233.
26. Nou ér SA, Nucci M, Kumar NS, et al . Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: Proposal for a new defi nition. Clin Infect Dis 2011; 53(7): 671-676.
27. Mokaddas E, Burhamah MH, Ahmad S, Khan ZU. Invasive pulmonary aspergillosis due to Aspergillus terreus: Value of DNA, galactomannan and (1- - 3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis. J Med Microbiol 2010; 59 :1519-1523.
28. Koo S, Bryar JM, Baden LR, Marty FM. Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol 2010; 48: 1255-1260.